Xenetic Biosciences, Inc. (XBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.69M |
| Enterprise Value | -4.19M |
| P/E Ratio | -1.05 |
| PEG Ratio | -0.25 |
| Price/Sales Ratio | 1.31 |
| Price/Book Ratio | 0.88 |
| Enterprise/Revenue | -0.65 |
| Enterprise/EBITDA | 0.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -1.24 |
| Operating Margin | -1.3 |
AD
Management Effectiveness
| Return On Assets | -0.58 |
| Return On Equity | -0.59 |
Income Statement
| Revenue | 2.98M |
| Revenue/Share | 1.26 |
| Gross Profit | 2.98M |
| EBITDA | -2.68M |
| Net Income | -2.68M |
| Diluted EPS | -1.58 |
Balance Sheet
| Total Cash | 5.81M |
| Total Cash/Share | 2.48 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.15 |
| Book Value Per Share | 1.88 |
Price History
| 52-Week Change | -37.12 |
| 52-Week High | 4.94 |
| 52-Week Low | 1.58 |
| Moving Average 50 Days | 2.53 |
| Moving Average 200 Days | 2.82 |
Statistics
| Average Volume | 73,917 |
| Shares Outstanding | 2.34M |
| % Held by Institutions | 3.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 15, 2023 |
AD
